Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Europe Finance Weekly.
Press releases published on March 27, 2025
Greystone Housing Impact Investors LP Issues 2,000,000 Series B Preferred Units
GlobeNewswire
·
March 27, 2025
OMAHA, Neb., March 27, 2025 (GLOBE NEWSWIRE) -- Greystone Housing Impact Investors LP (NYSE: GHI) (“the Partnership”) announced today that on March 26, 2025 the Partnership executed a Subscription Agreement to issue 2,000,000 additional Series B Preferred …
NextNRG Reports Strong Fourth Quarter and Full Year 2024 Financial Results
GlobeNewswire
·
March 27, 2025
Stronger Revenue, Improved Margins, and Expanded Volumes — FY 2024 Revenue Increased 20% to $27.8 Million from $23.2 Million in 2023 — — FY 2024 Gross Profit Grew 64% to $2.3 Million, Up from $1.4 Million in 2023 — — Q4 2024 Revenue Increased 21% to $6.9 …
Eloro Resources Announces Brokered Private Placement for Gross Proceeds of up to C$5.0 Million
GlobeNewswire
·
March 27, 2025
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES. TORONTO, March 27, 2025 (GLOBE NEWSWIRE) -- Eloro Resources Ltd. …
Nanobiotix Announces First Data From the Completed Dose Escalation Part of a Phase 1 Study Evaluating NBTXR3 (JNJ-1900) as a 2L+ Therapy for Patients With Locally Advanced NSCLC
GlobeNewswire
·
March 27, 2025
Data show favorable safety and confirm injection feasibility in 12 patients with locally advanced NSCLC amenable to re-irradiation for whom prior lines of therapy have failed A preliminary review of survival data showed 12-month LPFS of 64% (median 18.6 …
Nanobiotix annonce les premières données issues de la partie escalade de dose completée d’une étude de Phase 1 évaluant JNJ-1900 (NBTXR3) en traitement de 2L+ pour les patients atteints d’un CPNPC localement avancé
GlobeNewswire
·
March 27, 2025
Les données montrent un profil de sécurité favorable et confirment la faisabilité de l’injection chez 12 patients atteints d’un cancer du poumon (CPNPC) localement avancé éligibles à une ré-irradiation et pour lesquels les lignes de traitement antérieures …
Tempest Reports Year End 2024 Financial Results and Provides Business Update
GlobeNewswire
·
March 27, 2025
• Granted Both Orphan Drug …
Acuity Inc. Declares Quarterly Dividend
GlobeNewswire
·
March 27, 2025
Atlanta, March 27, 2025 (GLOBE NEWSWIRE) -- Acuity Inc. (NYSE: AYI) will pay a quarterly dividend of 17 cents per share. The dividend is payable on May 1, 2025, to shareholders of record on April 18, 2025. About Acuity Acuity Inc. (NYSE: AYI) is a …
INmune Bio Inc. Announces Year End 2024 Results and Provides a Business Update
GlobeNewswire
·
March 27, 2025
BOCA RATON, Fla., March 27, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, …
Elutia Announces GPO Agreement with Advantus Health Partners to Expand Access to EluPro™
GlobeNewswire
·
March 27, 2025
Seventh GPO Agreement Signed Since EluPro’s Launch SILVER SPRING, Md., March 27, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix products, announced that it has entered into an agreement …
CAMP4 Reports Full Year 2024 Financial Results and Provides Corporate Update
GlobeNewswire
·
March 27, 2025
– Phase 1 clinical trial of CMP-CPS-001 in Urea Cycle Disorders (UCDs) ongoing, with dosing completed in two of four multiple ascending dose (MAD) cohorts; safety, pharmacokinetic, and pharmacodynamic data anticipated in Q4 2025 – Initiation of expansion …
Global Water Completes $32.2 Million Public Offering of Common Stock; Underwriters Exercise Full Over-Allotment Option
GlobeNewswire
·
March 27, 2025
PHOENIX, March 27, 2025 (GLOBE NEWSWIRE) -- Global Water Resources, Inc. (NASDAQ: GWRS), a pure- play water resource management company, today announced that it completed a public offering of 3,220,000 shares of its common stock at a previously disclosed …
CTO Realty Growth Announces First Quarter 2025 Earnings Release and Conference Call Information
GlobeNewswire
·
March 27, 2025
WINTER PARK, Fla., March 27, 2025 (GLOBE NEWSWIRE) -- CTO Realty Growth (NYSE: CTO) (the “Company”) announced today that it will report its financial and operating results for the first quarter of 2025 after the market closes on Thursday, May 1, 2025. A …
Alpine Income Property Trust Announces First Quarter 2025 Earnings Release and Conference Call Information
GlobeNewswire
·
March 27, 2025
WINTER PARK, Fla., March 27, 2025 (GLOBE NEWSWIRE) -- Alpine Income Property Trust, Inc. (NYSE: PINE) (the “Company”) announced today that it will report its financial and operating results for the first quarter of 2025 after the market closes on Thursday, …
STRATA Skin Sciences Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides a Corporate Update
GlobeNewswire
·
March 27, 2025
HORSHAM, Pa., March 27, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of …
SeaStar Medical Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates
GlobeNewswire
·
March 27, 2025
DENVER, March 27, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life announced …
Accolade Stockholders Approve Merger Between Accolade and Transcarent
GlobeNewswire
·
March 27, 2025
SEATTLE, March 27, 2025 (GLOBE NEWSWIRE) -- Accolade (NASDAQ:ACCD) announced that Accolade stockholders voted to approve the merger with Transcarent at the Accolade special meeting of stockholders (the “Special Meeting”) held earlier today. The final, …
BioAtla Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Progress
GlobeNewswire
·
March 27, 2025
CAB-EpCAM x CAB-CD3 (BA3182) Phase 1 dose-escalation study continues with data readout expected mid-2025; Dose expansion data readout anticipated 1H 2026 Mecbotamab vedotin (CAB-AXL-ADC) Q2W dosing regimen associated with exceptional overall survival (OS) …
Clearside Biomedical Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
GlobeNewswire
·
March 27, 2025
- Successful End-of-Phase 2 Meeting with FDA Results in Alignment on Phase 3 Plans for CLS-AX in Wet AMD - - Asia-Pacific Partner’s New Drug Application for ARCATUS® (XIPERE®) for Uveitic Macular Edema Accepted for Regulatory Review in China - - Multiple …
Barfresh Provides Fourth Quarter and Full Year 2024 Results and Business Update
GlobeNewswire
·
March 27, 2025
Company Achieves Highest Fiscal Year Revenue in Company History Revenue of $10.7 Million, Gross Margin of 34% and Adjusted Gross Margin of 37% for Fiscal Year 2024 Pop …
Iridex Reports Fourth Quarter and Full Year 2024 Financial Results
GlobeNewswire
·
March 27, 2025
MOUNTAIN VIEW, Calif., March 27, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal …